Back
The Scotts Miracle Gro Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
60
SMG
The Scotts Miracle Gro
Last Price:
64.93
Seasonality Move:
0.97%
Buy
52
SRPT
Sarepta Therapeutics
Last Price:
157.93
Seasonality Move:
18.65%
Buy
60
The Scotts Miracle Gro (SMG)
is a Buy
Is The Scotts Miracle Gro a Buy, Sell or Hold?
- The current The Scotts Miracle Gro [SMG] share price is $65.06. The Score for SMG is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SMG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $157.74. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SMG Stock Price Chart
What is The Scotts Miracle Gro's stock price today?
-
The The Scotts Miracle Gro share price today is $65.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMG is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $157.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.
SMG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 44.29 | Sell |
| Chaikin Money Flow: | -1208638 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.73 - 67.77) | Sell |
| Bollinger Bands (100): | (62.09 - 71.43) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.67 | Buy |
| Relative Strength Index (14 RSI): | 68.69 | Buy |
| Chaikin Money Flow: | -86202 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.06 - 147.06) | Buy |
| Bollinger Bands (100): | (118.53 - 137.75) | Buy |
SMG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.94 | Sell |
| 20-day SMA: | 66.43 | Sell |
| 50-day SMA: | 67.42 | Sell |
| 200-day SMA: | 60.93 | Buy |
| 8-day EMA: | 66.13 | Sell |
| 20-day EMA: | 66.45 | Sell |
| 50-day EMA: | 66.98 | Sell |
| 200-day EMA: | 64.47 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 149.53 | Buy |
| 20-day SMA: | 132.97 | Buy |
| 50-day SMA: | 129.56 | Buy |
| 200-day SMA: | 115.84 | Buy |
| 8-day EMA: | 150.26 | Buy |
| 20-day EMA: | 138.97 | Buy |
| 50-day EMA: | 131.58 | Buy |
| 200-day EMA: | 121.41 | Buy |
The Scotts Miracle Gro Earnings Growth & SMG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $3.44 per share, an increase this year of $1.77 per share, and an increase next year of $1.19 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
The Scotts Miracle Gro Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||